Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1697388 | 0.82 | GPR35 (0.39) | GPR35 | |
| SCHEMBL19220750 | 0.81 | GPR35 (0.32) | GPR35 | |
| SCHEMBL407079 | 0.79 | GPR35 (0.46) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL559418 | 0.78 | GPR35 (0.37) | GPR35 | |
| SCHEMBL14110041 | 0.78 | SNCA (0.34) | GPR35 | |
| SCHEMBL22993626 | 0.77 | GPR35 (0.36) | GPR35 | |
| SCHEMBL18909187 | 0.75 | GPR35 (0.35) | GPR35 | |
| SCHEMBL10045600 | 0.75 | PKM (0.39) | GPR35 | |
| SCHEMBL13801951 | 0.75 | GPR35 (0.43) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5237137 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9310660-B2 | Organic compound and electrochromic element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-04-12 | — | — | US | disclosed |
| US-9310660-B2 | Organic compound and electrochromic element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-04-12 | — | — | US | disclosed |
| EP-2291427-B1 | SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS | SOLVAY USA INC (US) | 2016-03-30 | — | — | EP | disclosed |
| US-9147848-B2 | Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-09-29 | — | — | US | disclosed |
| US-9147848-B2 | Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-09-29 | — | — | US | disclosed |
| US-9147848-B2 | Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-09-29 | — | — | US | disclosed |
| US-20150153624-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2015-06-04 | — | — | US | disclosed |
| US-20150153624-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2015-06-04 | — | — | US | disclosed |
| US-20150141664-A1 | LOW BANDGAP DICYANOVINYL AND TRICYANOVINYL OLIGOTHIOPHENES FOR SOLAR CELL APPLICATIONS | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-05-21 | — | — | US | disclosed |
| US-20150141664-A1 | LOW BANDGAP DICYANOVINYL AND TRICYANOVINYL OLIGOTHIOPHENES FOR SOLAR CELL APPLICATIONS | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-05-21 | — | — | US | disclosed |
| US-8975419-B2 | Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-03-10 | — | — | US | disclosed |
| US-8975419-B2 | Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-03-10 | — | — | US | disclosed |
| US-8906520-B2 | Sulfonated polythiophenes comprising fused ring repeat units | SOLVAY USA, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-8906520-B2 | Sulfonated polythiophenes comprising fused ring repeat units | SOLVAY USA, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-8906520-B2 | Sulfonated polythiophenes comprising fused ring repeat units | SOLVAY USA, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-20140005411-A1 | LOW BANDGAP DICYANOVINYL AND TRICYANOVINYL OLIGOTHIOPHENES FOR SOLAR CELL APPLICATIONS | NANO AND ADVANCED MATERIALS INSTITUTE LIMITE (HK) | 2014-01-02 | — | — | US | disclosed |
| US-20110147725-A1 | SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS | PLEXTRONICS, INC. | 2011-06-23 | — | — | US | disclosed |
| US-20110147725-A1 | SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS | PLEXTRONICS, INC. | 2011-06-23 | — | — | US | disclosed |
| US-20110147725-A1 | SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS | PLEXTRONICS, INC. | 2011-06-23 | — | — | US | disclosed |
| WO-2009152165-A2 | SULFONATED POLYTHIOPHENES COMPRISING FUSED RING REPEAT UNITS | PLEXTRONICS, INC. (US) | 2009-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141664-A1 | LOW BANDGAP DICYANOVINYL AND TRICYANOVINYL OLIGOTHIOPHENES FOR SOLAR CELL APPLICATIONS | DSG1, CDC73, CDC23 | GPR35 1365/4885HDAC3 4121/4885HDAC4 3783/4885 |
| US-20150153624-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT INCLUDING THE SAME | ETV6, H1-0, HCN2 | GPR35 4624/4885HDAC3 2524/4885HDAC4 2803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.